Robert Half
RHI
$27.52
+5.24%
Robert Half Inc. is a specialized staffing and employment services firm providing temporary, permanent, and outcome-based staffing solutions primarily in finance, accounting, technology, legal, marketing, and administrative fields, operating within the fragmented U.S. staffing industry. The company is a well-established market leader and specialist, further distinguished by its subsidiary Protiviti, which offers consulting services in technology, risk, and compliance. The current investor narrative is dominated by the stock's significant underperformance relative to the broader market, with a 1-year price decline of 43.1% and a relative strength of -73.7%, reflecting deep concerns over cyclical pressures in the staffing sector, potential earnings contraction, and the sustainability of its dividend amidst this challenging operating environment.…
RHI
Robert Half
$27.52
Related headlines
Investment Opinion: Should I buy RHI Today?
Rating & Thesis: Hold. RHI is a deeply cyclical stock priced for distress, but the unsustainable dividend and lack of a clear fundamental catalyst warrant caution, despite the attractive valuation. The absence of a consensus analyst price target underscores the high uncertainty surrounding the name.
Supporting Evidence: The forward P/E of 11.2x is compelling for a market leader, and the P/S of 0.51x suggests the market is assigning little value to sales. The balance sheet is a clear strength, with a low debt-to-equity ratio of 0.33 providing financial flexibility. However, these positives are counterbalanced by a dangerously high dividend payout ratio of 179% and severely depressed profitability, with a net margin of only 2.47%. The stock's 43% one-year decline indicates the bad news is largely known, but a catalyst for recovery is not yet visible.
Risks & Conditions: The two biggest risks are a dividend cut and further earnings contraction. This Hold rating would upgrade to a Buy if the forward P/E compresses below 10x on sustained earnings growth or if the company provides clear guidance affirming dividend sustainability, signaling a trough in the cycle. It would downgrade to a Sell if the dividend is cut or if the price breaks decisively below the $21.83 support level on worsening fundamentals. Relative to its own distressed valuation, the stock appears fairly valued for the high level of risk it carries, but it is likely undervalued relative to a normalized mid-cycle earnings scenario.
Sign up to view all
RHI 12-Month Price Forecast
The investment case for RHI is a classic battle between deep value and cyclical risk. The valuation is compelling, and the balance sheet is robust, but the unsustainable dividend and depressed margins create a high degree of near-term uncertainty. The neutral stance reflects the high probability of a sideways, range-bound trading pattern (base case) as the market waits for clearer signs of a cyclical inflection point. The stance would upgrade to bullish on confirmation of dividend sustainability and sequential earnings improvement. It would turn bearish on a dividend cut or a breakdown below the $21.83 technical support, which would signal a new phase of fundamental deterioration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Robert Half's 12-month outlook, with a consensus price target around $35.78 and implied upside of +30.0% versus the current price.
Average Target
$35.78
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$22 - $36
Analyst target range
Analyst coverage for RHI is limited, with only 4 analysts providing estimates, which is low for a company of its size and suggests it may be under-followed by the institutional research community, potentially leading to higher volatility and less efficient price discovery. The available data provides consensus estimates for EPS and revenue but does not include a consensus price target, Buy/Hold/Sell distribution, or a target price range; the estimated EPS for the next period has a wide range from a low of $2.48 to a high of $3.33, indicating significant uncertainty among the few covering analysts about the company's near-term earnings power, which aligns with the stock's high volatility and challenging fundamental backdrop.
Bulls vs Bears: RHI Investment Factors
The evidence currently tilts bearish, with the unsustainable dividend and severe fundamental underperformance outweighing the attractive valuation. The most critical tension in the investment debate is the sustainability of the 8.76% dividend yield. If the company can maintain the payout through strong cash flow despite the high payout ratio, the stock could attract significant income-driven buying. However, a dividend cut—a high-probability event if earnings do not recover swiftly—would likely trigger another leg down in the share price. The bear case is supported by concrete financial metrics, while the bull case relies heavily on a cyclical rebound that is not yet evident in the company's margin profile or price action.
Bullish
- Deeply discounted valuation multiples: The stock trades at a forward P/E of 11.2x and a P/S ratio of 0.51x, which are low on an absolute basis and suggest the market has priced in significant pessimism. The forward P/E is nearly half the trailing P/E of 20.4x, implying expectations for a substantial earnings recovery.
- Strong balance sheet with low financial risk: A debt-to-equity ratio of 0.33 and a current ratio of 1.52 indicate a conservative capital structure and ample liquidity. This financial stability provides a buffer against cyclical downturns and supports the company's ability to maintain its dividend.
- Attractive dividend yield for income investors: The current dividend yield of 8.76% is exceptionally high, making the stock appealing for income-focused portfolios. However, this is tempered by a payout ratio of 179%, indicating the dividend is not currently covered by earnings and relies on cash reserves.
- Potential for cyclical rebound: As a staffing leader, RHI is highly sensitive to the economic cycle. The stock's 43% one-year decline and proximity to its 52-week low ($21.83) suggest it is positioned for a significant rally if macroeconomic conditions stabilize or labor demand recovers.
Bearish
- Unsustainable dividend payout ratio: A payout ratio of 179% is a major red flag, indicating the dividend is being paid from sources other than current earnings. This creates a high risk of a dividend cut, which would be a severe negative catalyst for the stock's income-focused investor base.
- Severe fundamental and price underperformance: The stock has declined 43.1% over the past year with a relative strength of -73.7% versus the SPY, reflecting deep market concerns over cyclical pressures. Low net and operating margins of 2.47% and 1.42%, respectively, confirm high sensitivity to an economic slowdown.
- High uncertainty in analyst earnings forecasts: With only 4 analysts covering the stock, consensus is thin. The wide range in estimated EPS for the next period ($2.48 low to $3.33 high) indicates significant disagreement and uncertainty about near-term profitability, contributing to volatility.
- Negative PEG ratio signals growth concerns: A PEG ratio of -0.45, despite the low forward P/E, suggests the market views any expected earnings growth as low quality or unsustainable. This reflects skepticism about the company's ability to navigate the current challenging staffing environment.
RHI Technical Analysis
The stock is in a pronounced and sustained downtrend, evidenced by a 1-year price change of -43.1% and a 6-month decline of -11.9%. As of the latest close at $25.61, the price is trading near the bottom of its 52-week range, approximately 8% above the 52-week low of $21.83 and 47% below the high of $48.54, positioning it as a potential value opportunity but also signaling persistent bearish momentum and significant fundamental headwinds. Recent momentum shows a slight short-term divergence, with a 1-month price increase of 4.45% against the severe longer-term downtrend, though this is overshadowed by a 3-month decline of -10.36% and a stark underperformance versus the SPY, which gained 8.7% over the past month, indicating any recent bounce is weak and lacks conviction relative to the market. Key technical support is firmly established at the 52-week low of $21.83, while resistance lies near the recent recovery high of $29.47 from April 22; a sustained breakdown below $21.83 would signal a continuation of the bear trend, whereas a breakout above $29.47 could suggest a more meaningful recovery is underway. The stock's beta of 0.841 indicates it has been less volatile than the market during this downturn, which is atypical for a cyclical name and may suggest it is experiencing idiosyncratic fundamental pressure.
Beta
0.84
0.84x market volatility
Max Drawdown
-60.3%
Largest decline past year
52-Week Range
$22-$49
Price range past year
Annual Return
-38.1%
Cumulative gain past year
| Period | RHI Return | S&P 500 |
|---|---|---|
| 1m | +10.8% | +12.2% |
| 3m | +2.1% | +2.3% |
| 6m | +3.6% | +4.7% |
| 1y | -38.1% | +29.2% |
| ytd | +0.7% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RHI Fundamental Analysis
Revenue and growth trajectory analysis is constrained as specific quarterly revenue and YoY growth figures are not available in the provided data; however, the severe stock price decline of -43.1% over one year and negative relative strength strongly imply the market is pricing in a significant deceleration or decline in revenue, a view partially supported by an estimated forward PE of 11.2, which suggests subdued growth expectations. Profitability metrics reveal a company under pressure, with a trailing net margin of only 2.47% and an operating margin of 1.42%, though it remains profitable with a positive EPS of $0.049; the gross margin of 37.2% is a relative strength, but the low operating and net margins indicate high operating leverage and sensitivity to cyclical downturns in staffing demand. The balance sheet and cash flow position appears stable, with a conservative debt-to-equity ratio of 0.33 and a healthy current ratio of 1.52, suggesting ample liquidity and low financial risk; the dividend yield of 8.76% and a payout ratio of 179% are critical figures, indicating the current dividend is likely unsustainable from earnings, posing a risk to the income-focused investor narrative if not supported by strong cash flow, for which specific data is unavailable.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RHI Overvalued?
Given the company is profitable with a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 20.45x, while the forward PE is significantly lower at 11.22x; this substantial gap implies the market expects a meaningful recovery in earnings over the next twelve months, though the negative PEG ratio of -0.45 suggests the market does not view this expected growth as high quality or sustainable. Peer comparison is limited as industry average multiples are not provided in the data; however, the stock's Price-to-Sales ratio of 0.51x and EV-to-Sales of 0.46x appear low on an absolute basis, potentially indicating a discount if these ratios are below sector norms, but this cannot be confirmed without benchmark data. Historical context for valuation is unavailable as historical ratio data is not provided; therefore, an assessment of whether the current trailing PE of 20.45x is near the top or bottom of its own historical range cannot be made, limiting the analysis of whether the stock is priced for optimism or pessimism relative to its own past.
PE
20.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the dividend's unsustainability, with a 179% payout ratio indicating it is not supported by current earnings of $0.049 per share. This poses a direct threat to the stock's core appeal to income investors. Furthermore, the company exhibits high operating leverage, with a gross margin of 37.2% collapsing to a net margin of just 2.47%, making profits highly sensitive to any revenue decline. While the balance sheet is strong (D/E 0.33), the business model is inherently cyclical and concentrated in the U.S. staffing market, leaving it vulnerable to domestic economic softening.
Market & Competitive Risks: The stock trades at a significant discount to its 52-week high (-47%), but this reflects justified concerns about cyclical compression. A key risk is that the forward P/E of 11.2x, while low, could compress further if earnings estimates are cut, as suggested by the wide analyst EPS range. The stock's beta of 0.84 indicates it has been less volatile than the market during its decline, which is unusual for a cyclical and may signal lingering, stock-specific fundamental pressure rather than broad market sentiment. The staffing industry is fragmented and competitive, and a prolonged economic downturn could lead to market share losses and permanent margin erosion.
Worst-Case Scenario: The worst-case scenario involves a continuation of the cyclical downturn in staffing demand, leading to a miss on the already uncertain analyst EPS estimates. This would likely force a dividend cut, triggering a sell-off from income-focused investors. Combined with a broader risk-off sentiment, the stock could re-test and break its 52-week low of $21.83. Given the stock's history of a -60.28% max drawdown, a realistic adverse scenario could see a decline of 15-20% from the current $25.61 price, resulting in a loss of approximately -35% to the 52-week low, landing in the low-$20s. This downside is amplified by the low analyst coverage, which can lead to exaggerated moves on negative news.
FAQ
The key risks are, in order of severity: 1) Dividend Cut Risk: The 179% payout ratio is unsustainable, and a reduction would crater the stock's income appeal. 2) Cyclical Earnings Risk: Low net margins (2.47%) make profits highly sensitive to an economic slowdown, risking further earnings declines. 3) Lack of Analyst Coverage: With only 4 analysts, the stock suffers from poor visibility and can gap on news. 4) Technical Downtrend: The stock is down 43% over the past year and could break to new lows below $21.83, triggering further selling.
Our 12-month forecast outlines three scenarios. The Base Case (50% probability) sees the stock trading between $26 and $30 as the cycle stabilizes. The Bull Case (25% probability) targets $34 to $40 on a strong economic and earnings recovery. The Bear Case (25% probability) warns of a drop to $20-$23 on a dividend cut and worsening fundamentals. The Base Case is most likely, hinging on the assumption that the company can navigate the downturn without cutting its dividend, allowing the stock to tread water until the cycle turns.
Based on traditional metrics, RHI appears undervalued. Its forward P/E of 11.2x and P/S ratio of 0.51x are low on an absolute basis and suggest the market expects minimal growth or even contraction. However, the negative PEG ratio of -0.45 indicates the market is skeptical of the quality of any expected growth. Compared to its own 52-week high of $48.54, it is deeply discounted. The valuation implies the market expects a prolonged downturn in the staffing cycle and has significant doubts about dividend sustainability.
RHI is a speculative buy only for investors with a high risk tolerance and a long-term horizon. The 8.76% dividend yield is attractive but carries a high risk of being cut, given the 179% payout ratio. The forward P/E of 11.2x is cheap and prices in a lot of bad news, but the stock lacks a near-term catalyst for recovery. It could be a good buy for deep-value contrarians betting on a cyclical rebound, but it is not suitable for conservative income investors or those seeking stable growth.
RHI is strictly a long-term investment for patient capital. The stock is in a cyclical downturn, and a recovery could take several quarters or years to materialize. Its high yield and low valuation are characteristics for a long-term, buy-and-hold value investor. It is poorly suited for short-term trading due to its low beta (0.84), which can lead to underperformance in rallies, and the high risk of a dividend-related negative catalyst. A minimum holding period of 2-3 years is suggested to potentially ride out the cycle.
